MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC).

Randall, LM; O'Malley, DM; Monk, BJ; Coleman, RL; Gaillard, S; Adams, SF; Duska, LR; Cappuccini, F; Dalton, H; Holloway, RW; Huang, M; Chon, HS; Cloven, NG; ElNaggar, A; O'Cearbhaill, RE; Waggoner, SE; Wang, Z; Zhi, E; Samnotra, V; Konstantinopoulos, PA

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索